BC Innovations | Jan 15, 2015
Finance

Consortia cross-talk

There's no doubt that the consortium model is here to stay, but the challenge now is to avoid creating a bureaucracy of committees with duplicate missions and redundancies of effort. The answer might be a...
BC Week In Review | Sep 8, 2014
Company News

Biocartis, Pronota diagnostic news

Biocartis spun out newco MyCartis (Lausanne, Switzerland), a combination of Pronota and Biocartis' Evalution unit, which was developing Biocartis' Evalution multiplex assay technology for protein and nucleic acid-based biomarker analysis. The technology was previously known...
BC Extra | Sep 5, 2014
Company News

Biocartis raises EUR 64.5M, spins out newco

Biocartis S.A. (Lausanne, Switzerland) raised EUR 64.5 million ($84.7 million) in an undisclosed venture round and separately spun out a newco, MyCartis, to develop the multiplex assay technology of Biocartis' Evalution business unit. The funding...
BC Week In Review | Nov 12, 2012
Company News

Metabolomic Diagnostics Ltd., Pronota diagnostic news

The EU awarded €6 million ($7.7 million) under its Seventh Framework Program (FP7) in research funding to the four-year Improved Pregnancy Outcomes via Early Detection (IMPROvED) consortium to develop a predictive preeclampsia diagnostic. The project,...
BC Week In Review | Jul 23, 2012
Clinical News

Mid-gestation pre-eclampsia screening test diagnostic data

A validation study in 300 women showed that Pronota's mid-gestation preeclampsia screening test correctly identified 80% of women who developed preeclampsia that resulted in premature birth. The SCreening fOr Pregnancy Endpoints (SCOPE) Consortium compiled the...
BC Week In Review | Mar 26, 2012
Company News

Pronota management update

Pronota N.V. , Zwijnaarde, Belgium   Business: Diagnostic, Pharmacogenetics   Hired: Carol Greve-Philips as CBO, formerly VP of corporate development at Genzyme Corp. , which Sanofi acquired; and Els Hubloux as CFO, formerly senior investment manager at...
BC Week In Review | Feb 28, 2011
Company News

Pronota, Mitsubishi Chemical deal

Pronota and Mitsubishi Chemical Holdings' Molecuence Corp. subsidiary partnered to discover and validate protein biomarkers to diagnose stroke. Pronota will use its MASStermind protein biomarker discovery platform and MASSterclass protein biomarker verification tool. Further terms...
BC Week In Review | May 24, 2010
Financial News

Pronota financial update

Pronota raised €1.5 million ($1.9 million) in a final close of a series B round, bringing the total raised in the round to €7.9 million. MedSciences Capital participated in the close. Pronota N.V. , Zwijnaarde, Belgium...
BC Week In Review | Nov 9, 2009
Financial News

Pronota financial update

Pronota raised €1.3 million ($2 million) in an extension of a series B round, bringing the total raised to €6.2 million ($8.8 million). MP Healthcare Venture Management participated. The company raised €4.9 million ($6.9 million)...
BC Week In Review | Jul 6, 2009
Financial News

Pronota completes venture financing

Pronota N.V. , Zwijnaarde, Belgium   Business: Diagnostic, Pharmacogenetics   Date completed: 6/29/09   Type: Venture financing   Raised: €4.9 million ($6.9 million)   Investors: LSP-Life Sciences Partners; Gimv N.V.; Biotech Fund Flanders; KBC Private Equity;...
Items per page:
1 - 10 of 26
BC Innovations | Jan 15, 2015
Finance

Consortia cross-talk

There's no doubt that the consortium model is here to stay, but the challenge now is to avoid creating a bureaucracy of committees with duplicate missions and redundancies of effort. The answer might be a...
BC Week In Review | Sep 8, 2014
Company News

Biocartis, Pronota diagnostic news

Biocartis spun out newco MyCartis (Lausanne, Switzerland), a combination of Pronota and Biocartis' Evalution unit, which was developing Biocartis' Evalution multiplex assay technology for protein and nucleic acid-based biomarker analysis. The technology was previously known...
BC Extra | Sep 5, 2014
Company News

Biocartis raises EUR 64.5M, spins out newco

Biocartis S.A. (Lausanne, Switzerland) raised EUR 64.5 million ($84.7 million) in an undisclosed venture round and separately spun out a newco, MyCartis, to develop the multiplex assay technology of Biocartis' Evalution business unit. The funding...
BC Week In Review | Nov 12, 2012
Company News

Metabolomic Diagnostics Ltd., Pronota diagnostic news

The EU awarded €6 million ($7.7 million) under its Seventh Framework Program (FP7) in research funding to the four-year Improved Pregnancy Outcomes via Early Detection (IMPROvED) consortium to develop a predictive preeclampsia diagnostic. The project,...
BC Week In Review | Jul 23, 2012
Clinical News

Mid-gestation pre-eclampsia screening test diagnostic data

A validation study in 300 women showed that Pronota's mid-gestation preeclampsia screening test correctly identified 80% of women who developed preeclampsia that resulted in premature birth. The SCreening fOr Pregnancy Endpoints (SCOPE) Consortium compiled the...
BC Week In Review | Mar 26, 2012
Company News

Pronota management update

Pronota N.V. , Zwijnaarde, Belgium   Business: Diagnostic, Pharmacogenetics   Hired: Carol Greve-Philips as CBO, formerly VP of corporate development at Genzyme Corp. , which Sanofi acquired; and Els Hubloux as CFO, formerly senior investment manager at...
BC Week In Review | Feb 28, 2011
Company News

Pronota, Mitsubishi Chemical deal

Pronota and Mitsubishi Chemical Holdings' Molecuence Corp. subsidiary partnered to discover and validate protein biomarkers to diagnose stroke. Pronota will use its MASStermind protein biomarker discovery platform and MASSterclass protein biomarker verification tool. Further terms...
BC Week In Review | May 24, 2010
Financial News

Pronota financial update

Pronota raised €1.5 million ($1.9 million) in a final close of a series B round, bringing the total raised in the round to €7.9 million. MedSciences Capital participated in the close. Pronota N.V. , Zwijnaarde, Belgium...
BC Week In Review | Nov 9, 2009
Financial News

Pronota financial update

Pronota raised €1.3 million ($2 million) in an extension of a series B round, bringing the total raised to €6.2 million ($8.8 million). MP Healthcare Venture Management participated. The company raised €4.9 million ($6.9 million)...
BC Week In Review | Jul 6, 2009
Financial News

Pronota completes venture financing

Pronota N.V. , Zwijnaarde, Belgium   Business: Diagnostic, Pharmacogenetics   Date completed: 6/29/09   Type: Venture financing   Raised: €4.9 million ($6.9 million)   Investors: LSP-Life Sciences Partners; Gimv N.V.; Biotech Fund Flanders; KBC Private Equity;...
Items per page:
1 - 10 of 26